Collectively, these above‐described results demonstrated that after the addition of EVs to lung cancer cells, KDM3A was down‐regulated, whereas the lung cancer cell proliferation, migration and invasion would be inhibited. The gene discussed is KDM3A; the disease is lung carcinoma.